Overview

Safety and Tolerability of Dabigatran Etexilate in Adolescents

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To investigate the safety and tolerability of dabigatran etexilate capsules in a small group of eight adolescent patients.
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Dabigatran